| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association between surgical quality and long-term survival in lung cancer
|
Lee, James D.
|
|
|
190 |
C |
p.
|
artikel
|
| 2 |
Association of patient and health care organization factors with incidental nodule guidelines adherence: A multi-system observational study
|
Slatore, Christopher G.
|
|
|
190 |
C |
p.
|
artikel
|
| 3 |
Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non–small cell lung cancer: KEYNOTE-782
|
Bar, Jair
|
|
|
190 |
C |
p.
|
artikel
|
| 4 |
Comment on: Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas
|
Yu, Tianfei
|
|
|
190 |
C |
p.
|
artikel
|
| 5 |
Contents
|
|
|
|
190 |
C |
p.
|
artikel
|
| 6 |
Describing differences among populations of thoracic tumors patients under and over 80 years: Data analysis from the SLCG thoracic tumor registry
|
Provencio, Mariano
|
|
|
190 |
C |
p.
|
artikel
|
| 7 |
Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study
|
Kim, Dong-Wan
|
|
|
190 |
C |
p.
|
artikel
|
| 8 |
Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine
|
Taverna, Josephine A.
|
|
|
190 |
C |
p.
|
artikel
|
| 9 |
Lazertinib as a frontline treatment in patients with EGFR-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201
|
Chul Cho, Byoung
|
|
|
190 |
C |
p.
|
artikel
|
| 10 |
Lung cancer detection in perioperative patients' exhaled breath with nanomechanical sensor array
|
Saeki, Yusuke
|
|
|
190 |
C |
p.
|
artikel
|
| 11 |
Malate, a natural inhibitor of 6PGD, improves the efficacy of chemotherapy in lung cancer
|
Sun, Mingming
|
|
|
190 |
C |
p.
|
artikel
|
| 12 |
On the Hispanic paradox in lung cancer
|
Rodriguez, John
|
|
|
190 |
C |
p.
|
artikel
|
| 13 |
Outcomes in patients treated with frontline immune checkpoint inhibition (ICI) for advanced NSCLC with KRAS mutations and STK11/KEAP1 comutations across PD-L1 levels
|
Sun, Lova
|
|
|
190 |
C |
p.
|
artikel
|
| 14 |
Outcomes of patients with advanced epithelial growth factor receptor mutant lung cancer treated with first-line osimertinib who would not have met the eligibility criteria for the FLAURA clinical trial
|
Connor Wells, J.
|
|
|
190 |
C |
p.
|
artikel
|
| 15 |
Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations
|
Hong, David S.
|
|
|
190 |
C |
p.
|
artikel
|
| 16 |
Population-based survival rates after curative surgical and non-surgical treatment of stage III NSCLC since 2017
|
Damhuis, R.A.M.
|
|
|
190 |
C |
p.
|
artikel
|
| 17 |
STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trial
|
Baptiste Oudart, Jean
|
|
|
190 |
C |
p.
|
artikel
|
| 18 |
Survival benefit in EGFR-wild and ALK negative NSCLC patients who participate in clinical trials compared to standard-of-care: Propensity-matched analysis
|
Jung, Hyun Ae
|
|
|
190 |
C |
p.
|
artikel
|
| 19 |
The Danish lung cancer registry: A nationwide validation study
|
Gouliaev, Anja
|
|
|
190 |
C |
p.
|
artikel
|
| 20 |
The impact of pre-treatment smoking status on survival after chemoradiotherapy for locally advanced non-small-cell lung cancer
|
Wallace, Neil D.
|
|
|
190 |
C |
p.
|
artikel
|
| 21 |
Uncommon de novo EGFRT790M-Mutant NSCLC characterized with unique genetic Features: Clinical response and acquired resistance to the third-generation EGFR-TKIs treatment
|
Pang, Lan-Lan
|
|
|
190 |
C |
p.
|
artikel
|
Tijdschrift beschrijving